|
Volumn 61 Suppl 2, Issue , 2004, Pages 49-52
|
Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group;Wyniki leczenia ostrej białaczki limfoblastycznej grupy standardowego ryzyka u dzieci wg zmodyfikowanego programu ALL BFM 90 w materiale Polskiej Pediatrycznej Grupy ds. Leczenia Białaczek i Chłoniaków.
a a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AIEOP ACUTE LYMPHOBLASTIC LEUKEMIA PROTOCOL;
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
BONE MARROW;
BONE TUMOR;
CENTRAL NERVOUS SYSTEM TUMOR;
CHILD;
FEMALE;
HUMAN;
INFANT;
MALE;
METASTASIS;
NEWBORN;
PATHOLOGY;
POLAND;
PRESCHOOL CHILD;
PROGNOSIS;
RECURRENT DISEASE;
REMISSION;
RETROSPECTIVE STUDY;
RISK FACTOR;
SURVIVAL;
TESTIS TUMOR;
TIME;
TREATMENT OUTCOME;
6-MERCAPTOPURINE;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
BONE MARROW;
BONE NEOPLASMS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
CHILD;
CHILD, PRESCHOOL;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
FEMALE;
HUMANS;
INFANT;
INFANT, NEWBORN;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
METHOTREXATE;
POLAND;
PREDNISONE;
PROGNOSIS;
RECURRENCE;
REMISSION INDUCTION;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SURVIVAL ANALYSIS;
TESTICULAR NEOPLASMS;
TIME FACTORS;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 16244385943
PISSN: 00332240
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|